We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Proposed Legislation Would Lift CMS Payment Rule for Antiamyloid Antibodies
Proposed Legislation Would Lift CMS Payment Rule for Antiamyloid Antibodies
A bipartisan bill just introduced in the U.S. House of Representatives seeks to abolish reimbursement restrictions placed on antiamyloid antibodies as a treatment for Alzheimer’s disease.